1. Home
  2. NWPX vs ESPR Comparison

NWPX vs ESPR Comparison

Compare NWPX & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NWPX
  • ESPR
  • Stock Information
  • Founded
  • NWPX 1966
  • ESPR 2008
  • Country
  • NWPX United States
  • ESPR United States
  • Employees
  • NWPX N/A
  • ESPR N/A
  • Industry
  • NWPX Steel/Iron Ore
  • ESPR Biotechnology: Pharmaceutical Preparations
  • Sector
  • NWPX Industrials
  • ESPR Health Care
  • Exchange
  • NWPX Nasdaq
  • ESPR Nasdaq
  • Market Cap
  • NWPX 420.8M
  • ESPR 445.6M
  • IPO Year
  • NWPX 1995
  • ESPR 2013
  • Fundamental
  • Price
  • NWPX $51.97
  • ESPR $2.77
  • Analyst Decision
  • NWPX Hold
  • ESPR Buy
  • Analyst Count
  • NWPX 1
  • ESPR 6
  • Target Price
  • NWPX $55.00
  • ESPR $6.50
  • AVG Volume (30 Days)
  • NWPX 55.8K
  • ESPR 6.1M
  • Earning Date
  • NWPX 10-29-2025
  • ESPR 11-06-2025
  • Dividend Yield
  • NWPX N/A
  • ESPR N/A
  • EPS Growth
  • NWPX 32.83
  • ESPR N/A
  • EPS
  • NWPX 3.32
  • ESPR N/A
  • Revenue
  • NWPX $499,125,000.00
  • ESPR $268,125,000.00
  • Revenue This Year
  • NWPX $4.00
  • ESPR $10.59
  • Revenue Next Year
  • NWPX $3.96
  • ESPR N/A
  • P/E Ratio
  • NWPX $15.65
  • ESPR N/A
  • Revenue Growth
  • NWPX 5.83
  • ESPR N/A
  • 52 Week Low
  • NWPX $36.97
  • ESPR $0.69
  • 52 Week High
  • NWPX $57.76
  • ESPR $3.94
  • Technical
  • Relative Strength Index (RSI)
  • NWPX 59.13
  • ESPR 77.93
  • Support Level
  • NWPX $50.26
  • ESPR $2.37
  • Resistance Level
  • NWPX $53.41
  • ESPR $2.73
  • Average True Range (ATR)
  • NWPX 1.28
  • ESPR 0.16
  • MACD
  • NWPX -0.36
  • ESPR 0.02
  • Stochastic Oscillator
  • NWPX 55.50
  • ESPR 93.92

About NWPX Northwest Pipe Company

NWPX Infrastructure Inc is a manufacturer of water-related infrastructure products. The Company is the manufacturer of engineered water transmission systems in North America and produces steel casing pipe, bar-wrapped concrete cylinder pipe, and pipeline system joints and fittings through its Engineered Steel Pressure Pipe segment. The Company provides solution-based products for a wide range of markets, including high-quality reinforced precast concrete products, lined precast sanitary sewer system components, water distribution and management equipment, including pump lift stations, wastewater pretreatment, and stormwater quality products through its Precast Infrastructure and Engineered Systems segment.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Share on Social Networks: